Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study

Aline Hajj, Roula El Hachem, Rita Khoury, +7

BMC Cancer

VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin’s disease

Vincent Ribrag, Fady Nasr, JH Bouhris, +10

Bone Marrow Transplantation

OncologyPathologyTherapeutic EfficacySalvage Intensification ProgramPharmacotherapy +3

Gemcitabine plus Carboplatin Combination Therapy as Second-Line Treatment in Patients with Relapsed Breast Cancer

Fady Nasr, G. Chahine, Joseph Kattan, +5

Clinical Breast Cancer

Second-line TreatmentCarboplatin Combination TherapyBreast OncologyRelapsed Breast CancerMedicine +5

Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC)

Joseph Kattan, F. Farhat, Georges Y. Chahine, +5

Investigational New Drugs

Zoledronic AcidUrologyMedicinePharmacologyWeekly Docetaxel +6

Clinical and genetic factors associated with self-reported cognitive deficits in women with breast cancer: the “CAGE-Cog” study

Aline Hajj, Rita Khoury, Roula El Hachem, +8

BMC Cancer

A Collaborative Nationwide Lymphoma Study in Lebanon: Incidence of Various Subtypes and Analysis of Associations with Viruses

Zaher K. Otrock, Jad Saab, Georges Aftimos, +29

Pathology & Oncology Research

Lymphoid NeoplasiaVirus EpidemiologyVirologyDisease OutbreakVarious Subtypes +4

Clinical and Genetic Factors Associated With the Breast Cancer-Related Sleep Disorders: The “CAGE-Sleep” Study–A Cross-Sectional Study

Aline Hajj, Roula El Hachem, Rita Khoury, +7

Journal of Pain and Symptom Management

Sleep MedicineSleepSleep HealthSleep DisordersSleep Disorder +9

Translocation t(4;11)(q21;q23) and MLL gene rearrangement in acute lymphoblastic leukemia secondary to anti topoisomerase II anticancer agents

Fady Nasr, Elizabeth Macintyre, A.M. Vénuat, +3

Leukemia & lymphoma/Leukemia and lymphoma

Hematological MalignancyTumor BiologyMedicineMll Gene RearrangementsMixed-phenotype Acute Leukemia +13

Lung Cancer and Immunotherapy: A Real-Life Experience from Second Line and Beyond

Fady El Karak, Roland Eid, Maya Al Ghor, +10

Future Oncology